Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver…
Revive Therapeutics Ltd. announced that it has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation of cannabidiol for the treatment of…
Read More...
Read More...
